STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] Kennedy-Wilson Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Kennedy-Wilson Holdings (KW): A Fairfax-led group and CEO William J. McMorrow formed a consortium and delivered a non-binding proposal to acquire all outstanding shares they do not already own for $10.25 per share in cash. The filing amends beneficial ownership and outlines the bid mechanics and expected independent Special Committee process.

The reporting persons disclose 30,950,036 shares beneficially owned, or 19.9%, reflecting a warrant exercise cap. Without that cap, their stake would be 38,703,549 shares (approximately 23.7% on an as-converted basis). They state the consortium may be deemed a “group” with 42,323,055 shares, or 27.2% of outstanding shares on an as-converted basis, and collectively about 31% including all underlying warrants. Shares outstanding were 137,899,795 as of August 4, 2025; the deemed outstanding count used for percentages is 155,527,822.

The proposal is expressly non-binding, with no assurance a definitive agreement will be reached, and the consortium reserves the right to modify or withdraw the offer.

Positive
  • None.
Negative
  • None.

Insights

Non-binding $10.25 cash bid; ownership group at 27.2%.

Fairfax and William J. McMorrow formed a consortium proposing to buy all outstanding KW shares they do not own for $10.25 per share. The filing details current beneficial ownership and how a 19.9% warrant exercise cap limits the reporting persons’ counted stake.

The filing states the consortium may be deemed a Section 13(d) “group” with 27.2% of shares on an as-converted basis, and about 31% including all underlying warrants held by consortium members. Governance-wise, the proposal anticipates a Special Committee with independent advisors.

Key dependencies include the Special Committee’s evaluation and any financing/transaction agreements. There is no assurance of a definitive deal, and the consortium may modify or withdraw. Subsequent company disclosures would clarify process steps if the Board engages further.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
The Shares beneficially owned by the Reporting Persons are held or issuable to pursuant to warrants. Certain of the warrants are subject to a limitation on a holder's right to exercise such warrants and received Shares that results in beneficial ownership in excess of 19.9% of the then-outstanding Shares or the voting power thereof, unless and until the requisite shareholder approval is obtained. As a result of such restriction, the Reporting Persons are deemed to beneficially own only 30,950,036 Shares. Without giving effect to such restriction, the Reporting Persons would be deemed to beneficially own 38,703,549 Shares, representing approximately 23.7% of the outstanding Shares on an as-converted basis.


SCHEDULE 13D




Comment for Type of Reporting Person:
The Shares beneficially owned by the Reporting Persons are held or issuable to pursuant to warrants. Certain of the warrants are subject to a limitation on a holder's right to exercise such warrants and received Shares that results in beneficial ownership in excess of 19.9% of the then-outstanding Shares or the voting power thereof, unless and until the requisite shareholder approval is obtained. As a result of such restriction, the Reporting Persons are deemed to beneficially own only 30,950,036 Shares. Without giving effect to such restriction, the Reporting Persons would be deemed to beneficially own 38,703,549 Shares, representing approximately 23.7% of the outstanding Shares on an as-converted basis.


SCHEDULE 13D




Comment for Type of Reporting Person:
The Shares beneficially owned by the Reporting Persons are held or issuable to pursuant to warrants. Certain of the warrants are subject to a limitation on a holder's right to exercise such warrants and received Shares that results in beneficial ownership in excess of 19.9% of the then-outstanding Shares or the voting power thereof, unless and until the requisite shareholder approval is obtained. As a result of such restriction, the Reporting Persons are deemed to beneficially own only 30,950,036 Shares. Without giving effect to such restriction, the Reporting Persons would be deemed to beneficially own 38,703,549 Shares, representing approximately 23.7% of the outstanding Shares on an as-converted basis.


SCHEDULE 13D




Comment for Type of Reporting Person:
The Shares beneficially owned by the Reporting Persons are held or issuable to pursuant to warrants. Certain of the warrants are subject to a limitation on a holder's right to exercise such warrants and received Shares that results in beneficial ownership in excess of 19.9% of the then-outstanding Shares or the voting power thereof, unless and until the requisite shareholder approval is obtained. As a result of such restriction, the Reporting Persons are deemed to beneficially own only 30,950,036 Shares. Without giving effect to such restriction, the Reporting Persons would be deemed to beneficially own 38,703,549 Shares, representing approximately 23.7% of the outstanding Shares on an as-converted basis.


SCHEDULE 13D




Comment for Type of Reporting Person:
The Shares beneficially owned by the Reporting Persons are held or issuable to pursuant to warrants. Certain of the warrants are subject to a limitation on a holder's right to exercise such warrants and received Shares that results in beneficial ownership in excess of 19.9% of the then-outstanding Shares or the voting power thereof, unless and until the requisite shareholder approval is obtained. As a result of such restriction, the Reporting Persons are deemed to beneficially own only 30,950,036 Shares. Without giving effect to such restriction, the Reporting Persons would be deemed to beneficially own 38,703,549 Shares, representing approximately 23.7% of the outstanding Shares on an as-converted basis.


SCHEDULE 13D




Comment for Type of Reporting Person:
The Shares beneficially owned by the Reporting Persons are held or issuable to pursuant to warrants. Certain of the warrants are subject to a limitation on a holder's right to exercise such warrants and received Shares that results in beneficial ownership in excess of 19.9% of the then-outstanding Shares or the voting power thereof, unless and until the requisite shareholder approval is obtained. As a result of such restriction, the Reporting Persons are deemed to beneficially own only 30,950,036 Shares. Without giving effect to such restriction, the Reporting Persons would be deemed to beneficially own 38,703,549 Shares, representing approximately 23.7% of the outstanding Shares on an as-converted basis.


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


V. PREM WATSA
Signature:/s/ V. Prem Watsa
Name/Title:V. Prem Watsa
Date:11/05/2025
THE SECOND 810 HOLDCO LTD
Signature:/s/ V. Prem Watsa
Name/Title:V. Prem Watsa, Director
Date:11/05/2025
THE SECOND 1109 HOLDCO LTD.
Signature:/s/ V. Prem Watsa
Name/Title:V. Prem Watsa, President
Date:11/05/2025
THE SIXTY TWO INVESTMENT COMPANY LIMITED
Signature:/s/ V. Prem Watsa
Name/Title:V. Prem Watsa, President
Date:11/05/2025
12002574 CANADA INC.
Signature:/s/ V. Prem Watsa
Name/Title:V. Prem Watsa, President
Date:11/05/2025
FAIRFAX FINANCIAL HOLDINGS LIMITED
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, President and Chief Operating Officer
Date:11/05/2025
FFHL GROUP LTD.
Signature:/s/ V. Prem Watsa
Name/Title:V. Prem Watsa, President
Date:11/05/2025
FAIRFAX (US) INC
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ODYSSEY GROUP HOLDINGS, INC.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ODYSSEY REINSURANCE CO
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
NEWLINE HOLDINGS UK LIMITED
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
NEWLINE CORPORATE NAME LIMITED
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
CRUM & FORSTER HOLDINGS CORP.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
UNITED STATES FIRE INSURANCE CO
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
THE NORTH RIVER INSURANCE COMPANY
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
TIG INSURANCE CO
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
RESOLUTION GROUP REINSURANCE (BARBADOS) LIMITED
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ZENITH NATIONAL INSURANCE CORP.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ZENITH INSURANCE COMPANY (CANADIAN ENTITY)
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
NORTHBRIDGE FINANCIAL CORPORATION
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
FAIRFAX (BARBADOS) INTERNATIONAL CORP.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
WENTWORTH INSURANCE COMPANY LTD.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
FAIRFAX UK HOLDINGS LIMITED
Signature:/s/ Michael Wallace
Name/Title:Michael Wallace, Director
Date:11/05/2025
BRIT GROUP HOLDINGS LIMITED
Signature:/s/ Gavin Wilkinson
Name/Title:Gavin Wilkinson, Group Chief Financial Officer
Date:11/05/2025
BRIT INSURANCE HOLDINGS LIMITED
Signature:/s/ Gavin Wilkinson
Name/Title:Gavin Wilkinson, Group Chief Financial Officer
Date:11/05/2025
BRIT SYNDICATES LIMITED
Signature:/s/ Gavin Wilkinson
Name/Title:Gavin Wilkinson, Group Chief Financial Officer
Date:11/05/2025
BRIT REINSURANCE (BERMUDA) LIMITED
Signature:/s/ Gavin Wilkinson
Name/Title:Gavin Wilkinson, Group Chief Financial Officer
Date:11/05/2025
1102952 B.C. UNLIMITED LIABILITY COMPANY
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ALLIED WORLD ASSURANCE COMPANY HOLDINGS, LTD
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ALLIED WORLD ASSURANCE COMPANY HOLDINGS I, LTD
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ALLIED WORLD ASSURANCE COMPANY, LTD
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ALLIED WORLD ASSURANCE HOLDINGS (IRELAND) LTD
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ALLIED WORLD ASSURANCE HOLDINGS (U.S.) INC.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ALLIED WORLD INSURANCE COMPANY
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
AW UNDERWRITERS INC.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ALLIED WORLD SPECIALTY INSURANCE COMPANY
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ALLIED WORLD SURPLUS LINES INSURANCE COMPANY
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ALLIED WORLD ASSURANCE COMPANY (U.S.) INC.
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
ALLIED WORLD ASSURANCE COMPANY (EUROPE) DAC
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
CRC REINSURANCE LIMITED
Signature:/s/ Peter Clarke
Name/Title:Peter Clarke, Attorney-in-Fact
Date:11/05/2025
Comments accompanying signature:
Attorney-in-Fact signing pursuant to powers of attorney referenced in Exhibits 99.17 and 99.18.
Kennedy-Wilson Holdings Inc

NYSE:KW

KW Rankings

KW Latest News

KW Latest SEC Filings

KW Stock Data

1.35B
119.07M
13.65%
85.22%
2.69%
Real Estate Services
Real Estate
Link
United States
BEVERLY HILLS